Controlled Group. (i) Abbott and any corporation, partnership and proprietorship under common control (as defined under the aggregation rules of subsections 414 (b), (c), or (m) of the Code) with Abbott; and (ii) during the period of the TAP Pharmaceutical Products Inc. (“TAP”) joint venture between Takeda Pharmaceutical Company Limited and Abbott ending April 30, 2008, TAP and any corporation, partnership and proprietorship under common control (as defined above) with TAP.
Appears in 39 contracts
Samples: Performance Restricted Stock Agreement, Performance Restricted Stock Unit Agreement (Abbott Laboratories), Performance Restricted Stock Agreement (Abbott Laboratories)
Controlled Group. (i) Abbott and any corporation, partnership and proprietorship under common control (as defined under the aggregation rules of subsections 414 (b414(b), (c), or (m) of the Code) with Abbott; and
(ii) during the period of the TAP Pharmaceutical Products Inc. (“TAP”) joint venture between Takeda Pharmaceutical Company Limited and Abbott ending April 30, 2008, TAP and any corporation, partnership and proprietorship under common control (as defined above) with TAP.
Appears in 4 contracts
Samples: Performance Restricted Stock Unit Agreement (Abbott Laboratories), Performance Restricted Stock Unit Agreement (Abbott Laboratories), Non Qualified Stock Option Agreement (Abbott Laboratories)
